Tuesday, 16 Feb 2010

Clinical data presented at the Joint Interventional Meeting (JIM) 2010 in Rome provide further evidence that Orbus Neich’s Genous stent could be a treatment of choice for patients not suitable for long-term dual antiplatelet therapy. [more]

Wednesday, 20 Jan 2010

Three-year results of the RESOLUTE trial include no new target lesion revascularisations and no instances of stent thrombosis. [more]

Tuesday, 19 Jan 2010

Since the first percutaneous implantation of a pulmonary valve in a human was reported for the first time in 2000, transcatheter heart valve procedures have recorded constant double-digit growth year-on-year, offering a new option to candidates not suitable for conventional surgery. [more]

Thursday, 07 Jan 2010

The results of the ARBITER 6-HALTS trial raised questions and prompted heated discussion at the American Heart Association scientific sessions. [more]

Thursday, 07 Jan 2010

New guidance recommending the use of prasugrel in combination with aspirin as an option for preventing blood clots in the arteries of people with acute coronary syndromes has been published by the National Institute for Health and Clinical Excellence (NICE). [more]

Friday, 04 Dec 2009

The latest progress in traditional heart surgery, minimally invasive and transcatheter techniques were presented in a two-day congress at the Heart Centre, University of Leipzig, Germany. [more]

Thursday, 03 Dec 2009

OrbusNeich have announced the initiation of patient enrolment in the randomised clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent). [more]

Friday, 06 Nov 2009

The transfemoral and transapical valve implantations were performed by Osaka University in preparation for application submission to the Japanese Ministry of Health, Labour and Welfare. [more]

Wednesday, 04 Nov 2009

Expanded indications for Abbott’s coronary stents are based on data from the SPIRIT family of randomised trials. [more]

Tuesday, 20 Oct 2009

Results for the Carpentier-Edwards Perimount Magna Ease valve were presented at the European Association for Cardio-Thoracic Surgery annual meeting, in Vienna, Austria. [more]

Friday, 09 Oct 2009

Abbott Vascular’s Xience V stent has been shown to be superior to other drug-eluting devices in two trials reported at the Transcatheter Cardiovascular Therapeutics 2009 annual meeting in San Francisco, California, USA. [more]

Friday, 09 Oct 2009

Two-year follow-up data from the HORIZONS-AMI trial presented at the TCT conference show that Taxus and bivalirudin maintained their advantage in ST segment elevation myocardial infarction patients that was shown at one year. [more]

Friday, 09 Oct 2009

The results of the PROSPECT trial show that the identification of lesions can be enhanced by intravascular ultrasound. [more]

Friday, 09 Oct 2009

Percutaneous heart valves get a boost as Abbott acquires Evalve. [more]

Tuesday, 06 Oct 2009

Two-year results of the LEADERS trial show an increasing trend towards a safety benefit for the biolimus A9-eluting stent with abluminal biodegradable polymer. [more]

Monday, 28 Sep 2009

Trial shows an FFR-guided strategy to treat multivessel coronary artery disease both improves outcomes and is cost-saving compared to procedures using angiography alone [more]

Monday, 28 Sep 2009

Pre-clinical data were presented at the TCT conference. OrbusNeich set to initiate patient enrolment in human clinical trial in fourth quarter. [more]

Monday, 28 Sep 2009

Minimised ExtraCorporeal Circulation (MECC) system offers new approach to improve patient safety during heart surgery. [more]

Monday, 28 Sep 2009

Data supporting the long-term safety and effectiveness of renal sympathetic denervation in treating patients with chronic hypertension were presented at the TCT conference. [more]

Wednesday, 23 Sep 2009

Three-year Taxus ATLAS results show safety and efficacy advantages for Boston Scientific Taxus Liberte Stent. [more]